11/15/2024
4:19 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
10:34 AM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
9:25 AM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/13/2024
7:30 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/12/2024
6:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:32 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A | |
10/31/2024
12:36 PM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G/A | |
|
10/31/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:05 PM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
10/08/2024
11:42 AM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G | |
10/02/2024
8:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:35 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/05/2024
8:03 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/03/2024
1:02 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G | |
05/29/2024
7:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
8:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:29 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:27 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:37 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024
3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:40 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:23 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:44 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:53 PM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
12:38 PM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
8:15 AM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
02/06/2024
4:09 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:04 PM | Eagle Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:56 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
6:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
4:00 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:01 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
12/22/2023
6:00 PM | Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K/A | |
12/20/2023
3:34 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:11 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:26 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:36 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
6:39 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
